May 28, 2021
The next generation of treatments for cancer may be found, not by scientists peering through microscopes, but by computer scientists crunching numbers. Thanks to unprecedented amounts of data, Purdue University researchers across multiple disciplines, including comparative pathobiology, are using innovative data science techniques to better understand the genetics and cellular biology of cancer cells and tumors allowing them to pioneer new diagnostic tools, generate novel therapeutic treatments, and significantly advance the fight against cancer. Among the researchers involved in this work is Dr. Nadia Lanman, who holds an appointment as research assistant professor in the College of Veterinary Medicine’s Department of Comparative Pathobiology.
January 26, 2021
Distinguished Professor of Comparative Oncology and Dolores L. McCall Professor of Comparative Oncology Deborah Knapp recently marked a milestone in her career. As an endowed professor, Purdue University requires Dr. Knapp undergo a review by her department every five years with the latest review completed last month. Dr. Knapp was first named the Dolores L. McCall Professor of Comparative Oncology in 2006 and has held the title ever since. As part of the review, Dr. Knapp was asked to present a seminar highlighting some of her research team’s success.
December 16, 2020
The National Cancer Institute announced in August the development of a cloud-based Canine Cancer Database that has significant ties to the Purdue University College of Veterinary Medicine.
December 11, 2020
As one of only seven basic laboratory cancer centers recognized by the National Cancer Institute, which is part of the National Institutes of Health, the Purdue University Center for Cancer Research (PCCR) connects more than 110 researchers from across the university, including faculty in the College of Veterinary Medicine. As the only NCI basic laboratory cancer center that includes a college of veterinary medicine, PCCR has the unique opportunity to study canine oncology while giving dogs chances to live longer, fuller lives.
December 11, 2020
A new approach to cancer immunotherapy has the potential to be a universal treatment for solid tumors, according to researchers at Purdue University, including a Distinguished Professor in Purdue Veterinary Medicine’s Department of Comparative Pathobiology. The research was led by Dr. Philip Low, Purdue’s Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry, and Dr. Timothy Ratliff, Distinguished Professor of Comparative Pathobiology and the Robert Wallace Miller Director of the Purdue Center for Cancer Research.
October 30, 2020
Each cancer patient’s tumors have cells that look and act differently, making it difficult for scientists to determine treatments based on tumors grown from generic cell cultures in the lab. Now, thanks to a new 3D cell culture technique developed by a team of Purdue University researchers, including College of Veterinary Medicine faculty member Sophie Lelièvre, it may be possible to personalize treatment by understanding the contributions of different cell types in a tumor to the cancer’s behavior.
September 11, 2020
The National Cancer Institute has announced the development of the Integrated Canine Data Commons (ICDC), which has significant ties to the Purdue University College of Veterinary Medicine. Developed by the Frederick National Laboratory for Cancer Research, the cloud-based repository of spontaneously arising canine cancer data was created with the goal of advancing human cancer research by enabling comparative analysis of canine cancer.
July 10, 2020
You can’t put a price on unconditional love and affection from a pet. But an avid animal-loving Indiana couple’s gratitude for the opportunity to spend more time with their beloved, cancer-stricken canine companion inspired a $1 million gift to support the Purdue Comparative Oncology Program (PCOP) that is part of the Purdue University College of Veterinary Medicine and an integral component of the Purdue University Center for Cancer Research (PCCR).
June 15, 2020
Dr. Marxa Figueiredo, associate professor of basic medical sciences in the College of Veterinary Medicine, played a leadership role on a team of Purdue University scientists who have created a new therapy option that may help halt tumor growth in certain cancers such as prostate, which is among the most common types of cancer in men.
April 10, 2020
Dr. Marxa Figueiredo, associate professor of basic medical sciences in the College of Veterinary Medicine, played a leadership role on a team of Purdue University scientists who have created a new therapy option that may help halt tumor growth in certain cancers such as prostate, which is among the most common types of cancer in men.
